• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康中国志愿者和高加索志愿者中透皮贴剂格拉司琼的群体药代动力学分析。

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers.

作者信息

Li Jiayu, Hu Pei, Zhou Li, Nagahama Fumiko, Chen Rui

机构信息

School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Front Pharmacol. 2023 Jun 26;14:1154026. doi: 10.3389/fphar.2023.1154026. eCollection 2023.

DOI:10.3389/fphar.2023.1154026
PMID:37435499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10330959/
Abstract

Granisetron patches are a prolonged delivery transdermal system that is used to prevent Chemotherapy-induced nausea and vomiting (CINV). To date, no pharmacokinetics comparison between Chinese and Caucasian populations has been conducted for granisetron patches. This study focused on the ethnic differences in pharmacokinetics (PK) of granisetron transdermal delivery system (GTDS) between Chinese and Caucasians and the influence of demographic covariates on pharmacokinetics (age, weight, height, body mass index, sex). To achieve this, blood concentration data were collected from 112 Caucasian healthy subjects participating in four clinical trials and 24 Chinese healthy subjects from one clinical trial, after a single application of the granisetron transdermal delivery system. A nonlinear mixed-effects model method of Phoenix NLME software was used to establish a population pharmacokinetic (Pop PK) model for Caucasian subjects. Bootstrap and visual predictive check (VPC) were used to validate the model. Based on the analysis a one-compartment model with first-order absorption and a first-order elimination well described the PK characteristics of GTDS. The apparent systemic clearance was determined to be 31316.3 mL/h and the central compartment volume of distribution was 6299.03 L. None of the five covariates (age, weight, height, body mass index, and sex) included in the Pop PK were significant covariates affecting PK. The final Pop PK model was used to simulate the Caucasian blood concentration by applying the dosing regimen used for the Chinese population. Comparison of the simulated Caucasian PK data with observed clinical PK data from Chinese healthy subjects revealed no significant differences in the main parameters, AUC and C, between the two groups. These findings suggested that no dose adjustment was required when applied to the Chinese population. In conclusion, this Pop PK study comparing the transdermal patch in Chinese and Caucasian healthy subjects provided valuable insights for optimizing dosage across ethnicities.

摘要

格拉司琼贴片是一种长效透皮给药系统,用于预防化疗引起的恶心和呕吐(CINV)。迄今为止,尚未对中国人群和白种人群之间的格拉司琼贴片进行药代动力学比较。本研究聚焦于中国人群和白种人群之间格拉司琼透皮给药系统(GTDS)药代动力学(PK)的种族差异,以及人口统计学协变量(年龄、体重、身高、体重指数、性别)对药代动力学的影响。为此,在单次应用格拉司琼透皮给药系统后,收集了参与四项临床试验的112名白种健康受试者和一项临床试验的24名中国健康受试者的血药浓度数据。使用Phoenix NLME软件的非线性混合效应模型方法为白种受试者建立群体药代动力学(Pop PK)模型。采用自举法和可视化预测检查(VPC)对模型进行验证。基于分析,具有一级吸收和一级消除的单室模型很好地描述了GTDS的PK特征。表观全身清除率确定为31316.3 mL/h,中央室分布容积为6299.03 L。Pop PK中纳入的五个协变量(年龄、体重、身高、体重指数和性别)均不是影响PK的显著协变量。最终的Pop PK模型用于通过应用中国人群使用的给药方案模拟白种人的血药浓度。将模拟的白种人PK数据与中国健康受试者观察到的临床PK数据进行比较,发现两组之间主要参数AUC和C无显著差异。这些发现表明,应用于中国人群时无需调整剂量。总之,这项比较中国和白种健康受试者透皮贴片的Pop PK研究为跨种族优化剂量提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/12a93ddd2b98/fphar-14-1154026-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/11e0eaed4e06/fphar-14-1154026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/4c39247d566b/fphar-14-1154026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/e24b0d47a82e/fphar-14-1154026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/ac57d2c899e1/fphar-14-1154026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/d04c41a74326/fphar-14-1154026-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/12a93ddd2b98/fphar-14-1154026-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/11e0eaed4e06/fphar-14-1154026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/4c39247d566b/fphar-14-1154026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/e24b0d47a82e/fphar-14-1154026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/ac57d2c899e1/fphar-14-1154026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/d04c41a74326/fphar-14-1154026-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e16f/10330959/12a93ddd2b98/fphar-14-1154026-g006.jpg

相似文献

1
Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers.健康中国志愿者和高加索志愿者中透皮贴剂格拉司琼的群体药代动力学分析。
Front Pharmacol. 2023 Jun 26;14:1154026. doi: 10.3389/fphar.2023.1154026. eCollection 2023.
2
Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.用于治疗化疗引起的恶心和呕吐的格拉司琼透皮系统的药代动力学
J Oncol Pharm Pract. 2009 Dec;15(4):223-31. doi: 10.1177/1078155209104063.
3
Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.罗替高汀透皮贴剂在健康的日本和高加索人群中的药代动力学、安全性和耐受性。
Clin Drug Investig. 2014 Feb;34(2):95-105. doi: 10.1007/s40261-013-0150-5.
4
Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study.透皮格拉司琼与帕洛诺司琼预防中度致吐性化疗后化疗引起的恶心和呕吐:一项多中心、随机、开放标签、交叉、活性对照的IV期研究。
Support Care Cancer. 2016 Feb;24(2):945-952. doi: 10.1007/s00520-015-2865-8. Epub 2015 Aug 12.
5
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.在中国患者中使用透皮格拉司琼预防中度或高度致吐性化疗后恶心和呕吐:一项随机、双盲、III期研究。
Chin Clin Oncol. 2016 Dec;5(6):79. doi: 10.21037/cco.2016.12.04.
6
Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects.聚乙二醇干扰素α-2b的群体药代动力学:健康白种人与中国受试者的比较
Front Pharmacol. 2021 May 28;12:673492. doi: 10.3389/fphar.2021.673492. eCollection 2021.
7
A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus.一项群体药代动力学研究,旨在加速新型药物特立氟胺钠治疗系统性红斑狼疮的早期临床开发。
Eur J Pharm Sci. 2019 Aug 1;136:104942. doi: 10.1016/j.ejps.2019.05.020. Epub 2019 May 30.
8
The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.首项儿科研究:西罗莫司的群体药代动力学及其在中国免疫性血细胞减少症儿童中的应用。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420934936. doi: 10.1177/2058738420934936.
9
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects.两种罗替高汀配方在中国健康受试者中的药代动力学、耐受性和生物等效性。
Clin Ther. 2018 Jul;40(7):1108-1121.e8. doi: 10.1016/j.clinthera.2018.05.009.
10
Population pharmacokinetic modeling of ilaprazole in healthy subjects and patients with duodenal ulcer in China.在中国健康受试者和十二指肠溃疡患者中进行的伊拉普唑群体药代动力学建模。
Front Pharmacol. 2024 Jan 10;14:1306222. doi: 10.3389/fphar.2023.1306222. eCollection 2023.

本文引用的文献

1
Physiologically based pharmacokinetic modelling to guide drug delivery in older people.基于生理学的药代动力学模型指导老年人的药物输送。
Adv Drug Deliv Rev. 2018 Oct;135:85-96. doi: 10.1016/j.addr.2018.08.013. Epub 2018 Sep 4.
2
CINV: still troubling patients after all these years.CINV:多年来仍困扰着患者。
Support Care Cancer. 2018 Mar;26(Suppl 1):5-9. doi: 10.1007/s00520-018-4131-3. Epub 2018 Mar 19.
3
Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
格拉司琼:化疗所致恶心和呕吐的药代动力学及临床经验综述
Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1289-1297. doi: 10.1080/17425255.2017.1396317. Epub 2017 Oct 27.
4
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.用于预测经多种酶途径代谢的药物在孕妇体内药代动力学的基于生理的药代动力学模型。
Clin Pharmacokinet. 2018 Jun;57(6):749-768. doi: 10.1007/s40262-017-0594-5.
5
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.在中国患者中使用透皮格拉司琼预防中度或高度致吐性化疗后恶心和呕吐:一项随机、双盲、III期研究。
Chin Clin Oncol. 2016 Dec;5(6):79. doi: 10.21037/cco.2016.12.04.
6
Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research.在诺华生物医学研究所的药物发现和开发早期研究阶段实施药代动力学和药效学策略。
Front Pharmacol. 2014 Jul 28;5:174. doi: 10.3389/fphar.2014.00174. eCollection 2014.
7
Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.甲氨蝶呤治疗类风湿关节炎的药代动力学和药效学的分子基础。
Drug Metab Pharmacokinet. 2014;29(1):12-9. doi: 10.2133/dmpk.dmpk-13-rv-119. Epub 2013 Nov 26.
8
Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.基于机制的生理药代动力学模型预测中国人与高加索人群细胞色素 P450 介导的药代动力学差异。
Clin Pharmacokinet. 2013 Dec;52(12):1085-100. doi: 10.1007/s40262-013-0089-y.
9
Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapy.经皮给予格拉司琼:在预防化疗引起的恶心和呕吐中的应用指南。
CNS Drugs. 2012 Sep 1;26(9):787-90. doi: 10.2165/11209440-000000000-00000.
10
Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption.预测经皮药物吸收后的浓度-时间曲线及其个体间变异性。
J Pharm Sci. 2012 Jul;101(7):2584-95. doi: 10.1002/jps.23155. Epub 2012 Apr 19.